The Financial Burden From Prescription Drugs Has Declined Recently For The Nonelderly, Although It Is Still High For Many.

Item request has been placed! ×
Item request cannot be made. ×
  Processing Request
  • Additional Information
    • Subject Terms:
    • NAICS/Industry Codes:
      325410 Pharmaceutical and medicine manufacturing
      414510 Pharmaceuticals and pharmacy supplies merchant wholesalers
      424210 Drugs and Druggists' Sundries Merchant Wholesalers
      923130 Administration of Human Resource Programs (except Education, Public Health, and Veterans' Affairs Programs)
    • Abstract:
      Prescription drug spending and pharmacy benefit design have changed greatly over the past decade. However, little is known about the financial impact these changes have had on consumers. We examined ten years of nationally representative data from the Medical Expenditure Panel Survey and describe trends in two measures of financial burden for prescription drugs: out-of-pocket drug costs as a function of family income and the proportion of all out-of-pocket health care expenses accounted for by drugs. We found that although the percentage of people with high financial burden for prescription drugs increased from 1999 to 2003, it decreased from 2003 to 2007, with a slight increase in 2008. The decline is evidence of the success of strategies to lower drug costs for consumers, including the increased use of generic drugs. However, the financial burden is still high among some groups, notably those with public insurance and those with low incomes. For example, one in four nonelderly people devote more than half of their total out-of-pocket health care spending to prescription drugs. These trends suggest that the affordability of prescription drugs under the future insurance exchanges will need to be monitored, as will efforts by states to increase prescription drug copayments under Medicaid or otherwise restrict drug use to reduce public spending. [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Health Affairs is the property of Project HOPE/HEALTH AFFAIRS and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
    • Author Affiliations:
      1assistant professor of medicine, University of Pittsburgh School of Medicine
      2associate professor, Department of Health Policy and Management, University of Pittsburgh Graduate School of Public Health.
      3research health scientist, Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System.
      4assistant professor of economics, University of Pittsburgh Graduate School of Public Health.
      5senior adviser, Division of Health and Human Resources, Congressional Budget Office, in Washington, D.C.
    • ISSN:
      0278-2715
    • Accession Number:
      10.1377/hlthaff.2011.0469
    • Accession Number:
      74530927
  • Citations
    • ABNT:
      GELLAD, W. F. et al. The Financial Burden From Prescription Drugs Has Declined Recently For The Nonelderly, Although It Is Still High For Many. Health Affairs, [s. l.], v. 31, n. 2, p. 408–416, 2012. DOI 10.1377/hlthaff.2011.0469. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=74530927&custid=s8280428. Acesso em: 10 dez. 2019.
    • AMA:
      Gellad WF, Donohue JM, Xinhua Zhao, Yuting Zhang, Banthin JS. The Financial Burden From Prescription Drugs Has Declined Recently For The Nonelderly, Although It Is Still High For Many. Health Affairs. 2012;31(2):408-416. doi:10.1377/hlthaff.2011.0469.
    • APA:
      Gellad, W. F., Donohue, J. M., Xinhua Zhao, Yuting Zhang, & Banthin, J. S. (2012). The Financial Burden From Prescription Drugs Has Declined Recently For The Nonelderly, Although It Is Still High For Many. Health Affairs, 31(2), 408–416. https://doi.org/10.1377/hlthaff.2011.0469
    • Chicago/Turabian: Author-Date:
      Gellad, Walid F., Julie M. Donohue, Xinhua Zhao, Yuting Zhang, and Jessica S. Banthin. 2012. “The Financial Burden From Prescription Drugs Has Declined Recently For The Nonelderly, Although It Is Still High For Many.” Health Affairs 31 (2): 408–16. doi:10.1377/hlthaff.2011.0469.
    • Harvard:
      Gellad, W. F. et al. (2012) ‘The Financial Burden From Prescription Drugs Has Declined Recently For The Nonelderly, Although It Is Still High For Many’, Health Affairs, 31(2), pp. 408–416. doi: 10.1377/hlthaff.2011.0469.
    • Harvard: Australian:
      Gellad, WF, Donohue, JM, Xinhua Zhao, Yuting Zhang & Banthin, JS 2012, ‘The Financial Burden From Prescription Drugs Has Declined Recently For The Nonelderly, Although It Is Still High For Many’, Health Affairs, vol. 31, no. 2, pp. 408–416, viewed 10 December 2019, .
    • MLA:
      Gellad, Walid F., et al. “The Financial Burden From Prescription Drugs Has Declined Recently For The Nonelderly, Although It Is Still High For Many.” Health Affairs, vol. 31, no. 2, Feb. 2012, pp. 408–416. EBSCOhost, doi:10.1377/hlthaff.2011.0469.
    • Chicago/Turabian: Humanities:
      Gellad, Walid F., Julie M. Donohue, Xinhua Zhao, Yuting Zhang, and Jessica S. Banthin. “The Financial Burden From Prescription Drugs Has Declined Recently For The Nonelderly, Although It Is Still High For Many.” Health Affairs 31, no. 2 (February 2012): 408–16. doi:10.1377/hlthaff.2011.0469.
    • Vancouver/ICMJE:
      Gellad WF, Donohue JM, Xinhua Zhao, Yuting Zhang, Banthin JS. The Financial Burden From Prescription Drugs Has Declined Recently For The Nonelderly, Although It Is Still High For Many. Health Affairs [Internet]. 2012 Feb [cited 2019 Dec 10];31(2):408–16. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=74530927&custid=s8280428